Sarepta Therapeutics (SRPT) Tops Q2 Earnings and Revenue Estimates

Sarepta Therapeutics (SRPT) came out with quarterly earnings of $2.02 per share, beating the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $0.07 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +81.98%. A quarter ago, it was expected that this biopharmaceutical company would post earnings of $0.35 per share when it actually produced a loss of $3.42, delivering a surprise of -1077.14%.Over the last fo ...